The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Search

      
      View

Article / Oct 10, 2015
Non-compliance is a competitive advantage in EuropeThe Economist, 10 October 2015

      View

Article / Nov 26, 2015
FDA Draft Guidance for Industry: Request for Quality Metrics – FDA-2015-D-2537Hovione's comments on the draft - FDA - Request for Quality Metrics, 26 November 2015

      View

Article / Dec 09, 2015
The importance of human factors in inhaler development: The making of PowdAir®Inhalation Magazine, December 2015

      View

Article / Feb 25, 2016
Continuous Processing: Meeting the Need for New Manufacturing StrategiesPublished in Pharma’s Almanac, February 2016

      View

Article / Feb 26, 2016
Making a SuccessEPM, January-February 2016

      View

Article / Mar 10, 2016
Hovione to build US plant for Vertex's cystic fibrosis drugsin-Pharma Technologist, March 10, 2016

      View

Article / Apr 06, 2016
Quality ForumFDA’s Inspection Programs

      View

Article / May 20, 2016
Japan’s generics market challenges foreign API makersC&EN, 20 May 2016

      View

Article / Jun 17, 2016
Quality Culture Wins Over CompliancePharma's Almanac, June 2016

      View

Article / Aug 30, 2016
Moving from compliance to quality cultureManufacturing Chemist, July/August 2016

Browser not supported

Search

Types

Press Room

Categories

Non-compliance is a competitive advantage in Europe

FDA Draft Guidance for Industry: Request for Quality Metrics – FDA-2015-D-2537

The importance of human factors in inhaler development: The making of PowdAir®

Continuous Processing: Meeting the Need for New Manufacturing Strategies

Making a Success

Hovione to build US plant for Vertex's cystic fibrosis drugs

Quality Forum

Japan’s generics market challenges foreign API makers

Quality Culture Wins Over Compliance

Moving from compliance to quality culture